Carcinogenesis, Vol. 23, No. 4, 645-655,
April 2002
© 2002 Oxford University Press
CARCINOGENESIS |
Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16INK4a and p14ARF ) and p53 genes are major targets for inactivation
1 Department of Biosciences, Karolinska Institute, Novum, 141 57 Huddinge, Sweden and
2 Division of Head and Neck Surgery, Cancer Institute, Chinese Academy of Medical, Science, Beijing, China
We determined inactivation of the CDKN2A (p16INK4a and p14ARF) gene in 21 cases of oesophageal squamous cell carcinoma (OSCC). The tumours were also analysed for mutations in exons 5–8 and allelic losses in the p53 gene. In addition, we screened the CDKN2B (p15 INK4b), CDKN2C (p18 INK4c), CDK4 and p53R2 genes for mutations in the tumour tissues. Besides concomitant alterations in the CDKN2A and p53 loci in more than half of the cases, our results showed that in 18 OSCC (86%) the CDKN2A (p16INK4a and p14ARF ) gene was affected through mutations, homozygous/hemizygous deletions and promoter hypermethylation. Eight out of 10 tumours with mutations or promoter hypermethylation specific to the CDKN2A/p16 INK4a gene showed loss of the wild-type allele. One tumour with a single base deletion in the N-terminus (codon 8) of the CDKN2A/p16INK4a gene carried a novel germ-line mutation or a rare polymorphism (Ile51Met) in exon 2 of the CDK4 gene. Promoter hypermethylation in the CDKN2A/p14 ARF gene was detected in 11 tumours. In the p53 gene 15 mutations were detected in 14 tumours. We detected an inverse relationship between CDKN2A/p16 INK4a inactivation and frequency of loss of heterozygosity at the p53 locus (OR 0.09, 95% CI 0.01–0.98; Fisher exact test, P-value ~0.03). Screening of nine exons of the p53R2 [Human Genome Organisation (HUGO) official name RRM2B] gene resulted in identification of a novel polymorphism in the 5' untranslated region, which was detected in four cases. Our results suggest that the CDKN2A (p16INK4a and p14ARF ) and p53 genes involved in the two cell cycle pathways are major and independent targets of inactivation in OSCC.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. Sailasree, A. Abhilash, K.M. Sathyan, K.R. Nalinakumari, S. Thomas, and S. Kannan Differential Roles of p16INK4A and p14ARF Genes in Prognosis of Oral Carcinoma Cancer Epidemiol. Biomarkers Prev., February 1, 2008; 17(2): 414 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. de Almeida Simao, G. L. De Bonis Almeida Simoes, F. S. Ribeiro, D. A. de Paula Cidade, N. A. Andreollo, L. R. Lopes, J. M. B. Macedo, R. Acatauassu, A. M. R. Teixeira, I. Felzenszwalb, et al. Lower expression of p14ARF and p16INK4a correlates with higher DNMT3B expression in human oesophageal squamous cell carcinomas Human and Experimental Toxicology, September 1, 2006; 25(9): 515 - 522. [Abstract] [PDF]
|
|
|
|
 |
|
 H. Okumura, S. Natsugoe, N. Yokomakura, Y. Kita, M. Matsumoto, Y. Uchikado, T. Setoyama, T. Owaki, S. Ishigami, and T. Aikou Expression of p53R2 Is Related to Prognosis in Patients with Esophageal Squamous Cell Carcinoma. Clin. Cancer Res., June 15, 2006; 12(12): 3740 - 3745. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Yamazaki, M Hasegawa, I Ohoka, K Hanami, A Asoh, T Nagao, I Sugano, and Y Ishida Increased E2F-1 expression via tumour cell proliferation and decreased apoptosis are correlated with adverse prognosis in patients with squamous cell carcinoma of the oesophagus J. Clin. Pathol., September 1, 2005; 58(9): 904 - 910. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. A. Shamanin and E. J. Androphy Immortalization of Human Mammary Epithelial Cells Is Associated with Inactivation of the p14ARF-p53 Pathway Mol. Cell. Biol., March 1, 2004; 24(5): 2144 - 2152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Worsham, G. Pals, J. P. Schouten, R. M. L. van Spaendonk, A. Concus, T. E. Carey, and M. S. Benninger Delineating Genetic Pathways of Disease Progression in Head and Neck Squamous Cell Carcinoma Arch Otolaryngol Head Neck Surg, July 1, 2003; 129(7): 702 - 708. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kumar and K. Hemminki Correspondence re: Zheng et al., Haplotype of Two Variants in p16 (CDKN2/MTS-1/INK4a) Exon 3 and Risk of Squamous Cell Carcinoma of the Head and Neck: a Case-Control Study. 11: 640-645, 2002 Cancer Epidemiol. Biomarkers Prev., January 1, 2003; 12(1): 71 - 71. [Full Text] [PDF]
|
|